About Us Medicines & Focus Research & Development Responsibility Investors News & Events Careers Medicines & Focus Innovation Focused on Complex Diseases Therapeutic Areas of Focus We are inspired by the courage and determination of individuals living with complicated and often difficult-to-treat diseases. We have a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Disease Areas Addiction We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid dependence. Serious Mental Illness We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with schizophrenia and bipolar I disorder. Cancer We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new treatment options. We Develop Innovative Medicines Alkermes’ technologies and discoveries have contributed to the development of medicines that have helped shape the treatment landscape, and form the basis for our current investigational products in a range of disease areas. Proprietary U.S. Medicines Our mission to make innovative medicines that may help address unmet patient needs underlies our work. Our portfolio of proprietary commercial products focuses on chronic, highly prevalent conditions that represent some of the most challenging health issues of our time. Our proprietary U.S. medicines Product Candidates in Development Our research and development efforts are focused on the pursuit of potential new medicines that build on our heritage in neuroscience and, as scientific opportunities present themselves, advancement of our research into important new areas such as immuno-oncology. Our R&D efforts Third-Party Medicines Our proprietary technologies are incorporated into third-party medicines that are commercialized by global pharmaceutical companies for people living with a range of serious diseases. Learn more about third-party medicines that utilize our proprietary technologies. U.S. medicines EU medicines Commitment to patients runs very deep at Alkermes. It starts when we discover new ideas in our labs, continues as we conduct clinical trials, make our medicines, educate stakeholders about unmet needs and support those who take our medicines. Contact Us Terms of Use Privacy Policy Sitemap © 2021 Alkermes. All rights reserved. Close Please review our Privacy Policy. By using our website without changing your cookie settings you agree to our use of Cookies as described in our Privacy Policy. Learn more